Sat.Aug 12, 2023 - Fri.Aug 18, 2023

article thumbnail

Upcoming DIR Fee Changes Still Causing Concern for Pharmacists

Drug Topics

New DIR fee rules eliminate clawbacks, but may create cashflow challenges for pharmacies in the first half of 2024.

469
469
article thumbnail

How an AstraZeneca exec is leading the charge in the next immuno-oncology era

PharmaVoice

The pharma giant’s head of immuno-oncology is now charging toward the next step in the cancer fight with long-term survival and precision.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Precision Medicine Has Broadened the Application of Gene Therapy Testing, Further Specialization May Be Needed to Interpret Results

Pharmacy Times

Opportunities for an additional specialization in molecular pathology may be helpful to train professionals in the real-time interpretation of gene therapy test results.

123
123
article thumbnail

Chutes & Ladders—Patrick J. Kennedy named strategic adviser, Mother's Milk Bank names new CEO

Fierce Healthcare

Chutes & Ladders—Patrick J.

98
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Food Is Medicine: Pharmacists Can Advance Policies for Healthier Communities

Drug Topics

It's an exciting time for policies being made around food as medicine.

469
469
article thumbnail

Demand for weight loss drugs soars to nearly half of Americans

PharmaVoice

Drugs like the buzzy Ozempic are high on consumers’ radar — but lofty barriers to access remain.

246
246

More Trending

article thumbnail

Turmeric for Your Thyroid and Hashimoto’s

The Thyroid Pharmacist

I love the concept of using food as medicine — or as I like to call it, food pharmacology. I became a pharmacist because I was interested in the effects that different substances have on human physiology. Medications are an obvious example of how tiny substances can produce a tremendous change in the human body, but what’s even more intriguing to me is the profound effect that foods and natural substances can have on the body.

Dosage 98
article thumbnail

Pharmacists Are On the Front Line of Women’s Health and Wellness

Drug Topics

Only 4% of money for research and development is used to focus on women’s health issues.

469
469
article thumbnail

Riding the mRNA wave, HDT Bio closes in on cancer-fighting vaccine

PharmaVoice

The company believes its platform could deliver safer and more efficient mRNA options for cancer and infectious diseases.

Vaccines 241
article thumbnail

Use of First-Line Treatment for Insomnia Low Among Adults With Mental Health Conditions

Pharmacy Times

Although the rate of people with probable insomnia who discussed their sleep habits with a physician was relatively high, the number of people who went on to seek actual treatment was low.

123
123
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Viome Life Sciences banks $86.5M round, partners with CVS to sell at-home diagnostic tests

Fierce Healthcare

At-home diagnostics startup Viome Life Sciences snagged $86.5 million in an oversubscribed series C funding round and will roll out its gut microbiome testing kit into 200 CVS stores. | At-home diagnostics startup Viome Life Sciences snagged $86.5 million in an oversubscribed series C funding round and will roll out its gut microbiome testing kit into 200 CVS stores.

98
article thumbnail

Illinois Governor Signs Legislation Targeting PBM Retaliation

Drug Topics

Illinois Governor JB Pritzker signed into a law a bill prohibiting PBM retaliation against pharmacists who disclose information during government proceedings.

469
469
article thumbnail

Behind Flagship Pioneering’s triumphs and tribulations

PharmaVoice

With Flagship and Pfizer’s newly announced partnership to find the next big blockbuster, we’re examining some of the VC fund’s biggest successes and failures to date.

130
130
article thumbnail

Understand the Underlying Causes, Challenges of Treating Obesity

Pharmacy Times

Guidelines from the American Academy of Pediatrics recommend treating obesity as a chronic illness.

123
123
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Why so few get screened for lung cancer, the deadliest cancer in the U.S.

STAT

It was Thanksgiving 2021, and Michael Young was at Target buying a turkey baster. “I’m in the parking lot, and my chest starts to feel like somebody’s sitting on me,” Young recounted. But he didn’t think too much of it and waited until February to tell the doctor about these on-and-off chest pains. “8:30 a.m.

98
article thumbnail

Chikungunya Vaccine for Adolescents Shows Positive Topline Results in Phase 3 Trial

Drug Topics

PXVX0317 has received Fast Track and Breakthrough Therapy designation from the FDA.

Vaccines 468
article thumbnail

Woman of the Week: Novartis’ Christy Siegel

PharmaVoice

The oncology portfolio general manager for breast and women’s cancers, discusses the company’s recent “landmark” trial and how her family’s history connects her to patients.

130
130
article thumbnail

Experts Discuss "Cosmetics With Cause," Empowering Women

Pharmacy Times

Experts Christina Madison, PharmD, FCCP, AAHIVP, and Joy Hoover, founder of Esōes Cosmetics, sat down to discuss how cosmetics can empower users of all genders.

123
123
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

List prices for Ozempic, Wegovy far higher in the US than in peer nations: KFF

Fierce Healthcare

It's not a secret that Americans pay far more than people living in other countries for drugs, and those data hold for trendy weight loss and diabetes treatments as demand for these therapies grows | It's not a secret that Americans pay far more than people living in other countries for drugs, and those data hold for trendy weight loss and diabetes treatments like Ozempic and Wegovy.

98
article thumbnail

Expert Interview: Exploring the Full Capabilities of Generative AI

Drug Topics

Generative AI is the fastest growing technology ever, and is anticipated to be adopted faster than the world wide web.

460
460
article thumbnail

Pharma’s rare disease rush

PharmaVoice

Biogen’s acquisition of Reata Pharmaceuticals is the latest in a string of high-dollar rare disease deals over the last few months. What does it mean for industry?

130
130
article thumbnail

Vermont’s Prescribed Products Gift Ban and Disclosures Act

Pharmacy Times

The law has impacted the number of physicians receiving payment from drug companies.

123
123
article thumbnail

Ex-UK deputy medical officer Van-Tam takes role at Moderna

pharmaphorum

Ex-UK deputy medical officer Van-Tam takes role at Moderna Phil.

98
article thumbnail

MorningRX: August 18, 2023

Drug Topics

NIH establishes research centers for maternal health, FDA grants priority review for IgA nephropathy treatment, and the CDC begins tracking a new COVID-19 variant.

FDA 247
article thumbnail

STAT+: An innovative eye stem cell transplant could help restore vision in people with chemical injuries

STAT

The first time Phillip Durst saw the big A on the chart, he could hardly believe it. It was the first in a series of letters to check his vision in his left eye. “They keep flipping the chart and it keeps getting smaller and smaller, and I keep identifying the letters — that was huge,” said Durst. “It’s like a miracle.

98
article thumbnail

Receiving SARS-CoV-2 Booster During Pregnancy May Improve Newborn’s Immune Responses to Virus

Pharmacy Times

A COVID-19 booster dose increased both maternal and cord blood binding and neutralizing antibody levels against virus strains, including Omicron BA.1.

article thumbnail

Improving treatment for high-risk cataract surgery

pharmaphorum

Improving treatment for high-risk cataract surgery Mike.

98
article thumbnail

What You Need to Know About the Drug Supply Chain Security Act Before November’s Deadline

Drug Topics

A Q&A with Matt Sample, senior vice president of manufacturer and replenishment operations at AmerisourceBergen.

247
247
article thumbnail

Opinion: Medicine robs physicians of their fertility. Here’s how to fix it

STAT

“T he Retrievals,” a disturbing podcast from Serial and the New York Times released this summer, painstakingly tells the stories of women who sought fertility treatments at the Yale Fertility Center in 2020. Over the course of five months, women underwent egg retrievals without any pain medication. Although this procedure is typically done under heavy sedation, a nurse at the clinic had replaced fentanyl with saline.

98
article thumbnail

Study: Healthy, Born-at-Term Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infections Need Intensive Care

Pharmacy Times

The findings of the study demonstrate the need for preventive interventions for all infants in order to reduce the burden of severe illness from respiratory syncytial virus lower respiratory tract infections.

123
123
article thumbnail

Health Innovators – Dr Jack Hoppin and Dr John Babich (follow-up)

pharmaphorum

Health Innovators – Dr Jack Hoppin and Dr John Babich (follow-up) Mike.

98
article thumbnail

Podcast: Is The Pharmacy World Prepared For DSCSA?

Drug Topics

Todd Eury of the Pharmacy Podcast Network is joined by Josh Bolin of the NABP to talk about DSCSA, what benefits it will provide, and how to make sure your pharmacy is ready when it goes into effect this November.

247
247
article thumbnail

ProMED sees offers of support, but its future remains unclear

STAT

With its future in doubt, ProMED, the financially strapped infectious diseases surveillance network, has seen waves of support pour in in recent weeks, with universities and other funders seeking to rescue it, according to the president of the committee that oversees it. Both the International Society for Infectious Diseases, which has hosted ProMED since 1999, and its moderators, many of whom went on strike earlier this month to protest plans to put the service behind a paywall, have been in di

98